These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6651526)

  • 1. Effect of multiple administration of orphenadrine or mono-N-desmethylorphenadrine on cytochrome P-450 catalyzed reactions in the rat.
    Bast A; Savenije-Chapel EM; van Kemenade FA; Scheefhals LW; Noordhoek J
    Arch Toxicol; 1983 Oct; 54(2):131-7. PubMed ID: 6651526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Product inhibition in orphenadrine metabolism as a result of a stable cytochrome P-450-metabolic intermediate complex formed during the disposition of mono-N-desmethylorphenadrine (tofenacine) in the rat.
    Bast A; van Kemenade FA; Savenije-Chapel EM; Noordhoek J
    Res Commun Chem Pathol Pharmacol; 1983 Jun; 40(3):391-403. PubMed ID: 6622816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of nefopam and orphenadrine with the cytochrome P-450 and the glutathione system in rat liver.
    Leurs R; Donnell D; Timmerman H; Bast A
    J Pharm Pharmacol; 1989 Jun; 41(6):388-93. PubMed ID: 2570834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
    Reidy GF; Mehta I; Murray M
    Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between molecular structure and cytochrome P450-metabolic intermediate complex formation, studied with orphenadrine analogues.
    Bast A; Savenije-Chapel EM; Noordhoek J
    J Pharm Sci; 1984 Jul; 73(7):953-6. PubMed ID: 6470960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 metabolic intermediate complex of nefopam.
    Leurs R; Donnell D; Timmerman H; Bast A
    J Pharm Pharmacol; 1987 Oct; 39(10):835-7. PubMed ID: 2891822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for complexation of P-450 IIC6 by an orphenadrine metabolite.
    Reidy GF; Murray M
    Biochem Biophys Res Commun; 1990 Jan; 166(2):772-9. PubMed ID: 2302238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the substrate analogue of cytochrome P-450 and mixed function oxidases.
    Popova VI; Leonova IN; Weiner LM; Salganik RI
    Biochem Pharmacol; 1982 Jun; 31(11):1993-8. PubMed ID: 6288047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminopyrine metabolism by multiple forms of cytochrome P-450 from rat liver microsomes: simultaneous quantitation of four aminopyrine metabolites by high-performance liquid chromatography.
    Imaoka S; Inoue K; Funae Y
    Arch Biochem Biophys; 1988 Aug; 265(1):159-70. PubMed ID: 3415241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolite complex formation of orphenadrine with cytochrome P450. Involvement of CYP2C11 and CYP3A isozymes.
    Roos PH; Mahnke A
    Biochem Pharmacol; 1996 Jul; 52(1):73-84. PubMed ID: 8678911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cytochrome P-450 content and activities in liver microsomes of seven animal species, including man.
    Souhaili-el Amri H; Batt AM; Siest G
    Xenobiotica; 1986 Apr; 16(4):351-8. PubMed ID: 3087069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectral interaction of orphenadrine and its metabolites with oxidized and reduced hepatic microsomal cytochrome P-450 in the rat.
    Bast A; Noordhoek J
    Biochem Pharmacol; 1982 Sep; 31(17):2745-53. PubMed ID: 7138571
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of certain vitamin deficiencies on hepatic drug metabolism.
    Zannoni VG; Sato PH
    Fed Proc; 1976 Nov; 35(13):2464-9. PubMed ID: 976490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common multiple interactions of tricyclic anti-depressants and orphenadrine with liver microsomal cytochrome P450 enzymes of the rat.
    Roos PH
    Xenobiotica; 1999 Jun; 29(6):629-40. PubMed ID: 10426561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic acetone administration on ethanol-inducible monooxygenase activities in the rat.
    Hétu C; Joly JG
    Biochem Pharmacol; 1988 Feb; 37(3):421-6. PubMed ID: 3122762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibitory interactions of alkoxymethylenedioxybenzenes towards mono-oxygenase activity in rat-hepatic microsomes.
    Murray M; Hetnarski K; Wilkinson CF
    Xenobiotica; 1985 May; 15(5):369-79. PubMed ID: 4036165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the oral contraceptive, menstranol, on drug-metabolizing enzymes of female rats in thiamin-supplemented and deficiency states.
    Wade AE; Evans JL; Seitz A
    Pharmacology; 1976; 14(2):104-14. PubMed ID: 822434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of benznidazole on the mixed function oxygenase system from rat liver microsomes.
    Masana M; de Toranzo EG; Rubio M; Castro JA
    Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):4-11. PubMed ID: 4051638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes.
    Ren S; Yang JS; Kalhorn TF; Slattery JT
    Cancer Res; 1997 Oct; 57(19):4229-35. PubMed ID: 9331082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline.
    Murray M
    Mol Pharmacol; 1992 Nov; 42(5):931-8. PubMed ID: 1435757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.